Protalix BioTherapeutics sets March 22, 2023 for TASE delisting; will remain on NYSE American

Protalix BioTherapeutics, Inc.

Delisting from Tel Aviv Stock Exchange effective March 22, 2023; last trading day March 20, 2023.
Common stock will continue to be listed and trade on NYSE American under symbol PLX.
Israeli shareholders urged to contact their brokers to transfer shares to a NYSE American-based account.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.